Project 'GeneWeaver' - CRISPR Therapy Platform
An end-to-end platform for the development and delivery of CRISPR-based therapies. It includes an AI for identifying off-target risks, a system for designing optimal guide RNA, and a novel, non-viral delivery vector to safely get the genetic editing machinery into target cells.
Visual Concept
No images were provided for this innovation.
Click Analyze to get AI-powered insights
An end-to-end platform for the development and delivery of CRISPR-based therapies. It includes an AI for identifying off-target risks, a system for designing optimal guide RNA, and a novel, non-viral delivery vector to safely get the genetic editing machinery into target cells.
